Stock Market News1 month Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study Zacks
Data from a late-stage study shows that LLY’s experimental oral drug benefited certain breast cancer patients when used as both a combination and monotherapy.
XData from a late-stage study shows that LLY’s experimental oral drug benefited certain breast cancer patients when used as both a combination and monotherapy.
X